Table 2

Medications given to patients alive at discharge*, and outcomes for all patients, according to stroke type
OUTCOMES* Ischemic Hemorrhagic p-value** Trend p-value
N (%) 328 366 - -
Modified Rankin score at discharge, % 0.2 <0.001
  No disability 0.9 0.2
  No significant disability 8.5 3.4
  Slight disability 10.7 6.2
  Moderate disability, able to walk 21.8 12.0
  Moderate disability, unable to walk 17.0 11.1
  Severe disability 37.7 57.8
  Dead 3.5 9.4
Modified Rankin score at discharge, mean 3.81 4.78 <0.001
Discharge status, % <0.001
  Alive 81.2 50.5
  Dead 3.6 9.4
  Discharged to die 15.3 40.1
28-day Mortality 20.3 51.0 <0.001
MEDICATIONS AT DISCHARGE+
Anticoagulants in-hospital, % 2.3 0.5 0.2
Antidiabetics in-hospital, % 8.5 4.0 0.10
Antiplatelets in-hospital, % 49.5 1.5 <0.001
Cholesterol lowering medications in-hospital, % 38.9 23.6 0.001
Antihypertensives, % 55.7 77.5 <0.001

*Missing values multiply imputed.

**P-value for F-test of univariate model with single categorical variable with n-1 degrees of freedom where n=number of categories.

+Excludes patients who died in hospital and patients discharged to die at home.

Tirschwell et al.

Tirschwell et al. BMC Neurology 2012 12:150   doi:10.1186/1471-2377-12-150

Open Data